BeiGene Breaks Ground on New Manufacturing, Clinical R&D Center in Hopewell

General Business Flagship U.S. Facility Will Include Biologic Manufacturing and Late Stage Research and Clinical Development of Innovative Cancer Medicines On Apr 29, 2022 BeiGene, Ltd, a global biotechnology company, announced the groundbreaking of its flagship U.S. manufacturing and clinical R&D center at the Princeton West Innovation Campus in Hopewell. The initial phase of construction…

Read More